Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.

[1]  Oliver Kripfgans,et al.  Characterization of Macrolesions Induced by Myocardial Cavitation-Enabled Therapy , 2015, IEEE Transactions on Biomedical Engineering.

[2]  Douglas L. Miller,et al.  Timing of high-intensity pulses for myocardial cavitation-enabled therapy , 2014, Journal of therapeutic ultrasound.

[3]  Nathan McDannold,et al.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system , 2014, Defense + Security Symposium.

[4]  Nico de Jong,et al.  Acoustic behavior of microbubbles and implications for drug delivery. , 2014, Advanced drug delivery reviews.

[5]  P. Grayburn,et al.  Cardiovascular drug delivery with ultrasound and microbubbles. , 2014, Advanced drug delivery reviews.

[6]  Douglas L. Miller,et al.  Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application. , 2014, Ultrasound in medicine & biology.

[7]  Shuxian Song,et al.  Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Kullervo Hynynen,et al.  Drug delivery across the blood–brain barrier using focused ultrasound , 2014, Expert opinion on drug delivery.

[9]  Ryan M. Jones,et al.  Three-Dimensional Transcranial Ultrasound Imaging of Microbubble Clouds Using a Sparse Hemispherical Array , 2014, IEEE Transactions on Biomedical Engineering.

[10]  N. Nanda,et al.  Live/Real Time Three‐Dimensional Transesophageal Echocardiographic Assessment of Ventricular Septal Volume and Mass before and after Myectomy in Hypertrophic Cardiomyopathy , 2013, Echocardiography.

[11]  K. H. Martin,et al.  Current status and prospects for microbubbles in ultrasound theranostics. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[12]  L. Du,et al.  Drug-loaded nano-microcapsules delivery system mediated by ultrasound-targeted microbubble destruction: A promising therapy method. , 2013, Biomedical reports.

[13]  Sadik Esener,et al.  Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment , 2013, Drug design, development and therapy.

[14]  Francois Vignon,et al.  Microbubble cavitation imaging , 2013, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[15]  T. D. Mast,et al.  Passive imaging with pulsed ultrasound insonations. , 2012, The Journal of the Acoustical Society of America.

[16]  John Eisenbrey,et al.  Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. , 2011, International journal of pharmaceutics.

[17]  Douglas L. Miller,et al.  Are ECG premature complexes induced by ultrasonic cavitation electrophysiological responses to irreversible cardiomyocyte injury? , 2011, Ultrasound in medicine & biology.

[18]  M. Schloesser,et al.  Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. , 2011, Journal of the American College of Cardiology.

[19]  S. Ommen,et al.  Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you. , 2010, Circulation. Cardiovascular interventions.

[20]  D. Simel,et al.  Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy: Comparative Rates of Overall Mortality and Sudden Cardiac Death After Treatment , 2010, Circulation. Cardiovascular interventions.

[21]  T. D. Mast,et al.  Passive cavitation imaging with ultrasound arrays. , 2009, The Journal of the Acoustical Society of America.

[22]  D. McPherson,et al.  Cardiovascular therapeutic uses of targeted ultrasound contrast agents. , 2009, Cardiovascular research.

[23]  M. Borden,et al.  Microbubble size isolation by differential centrifugation. , 2009, Journal of colloid and interface science.

[24]  K. Fujikura,et al.  Extracardiac ablation of the left ventricular septum in beating canine hearts using high-intensity focused ultrasound. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  Douglas L. Miller,et al.  Simulation of diagnostic ultrasound image pulse sequences in cavitation bioeffects research. , 2007, The Journal of the Acoustical Society of America.

[26]  Douglas L. Miller,et al.  Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. , 2005, Radiology.

[27]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[28]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[29]  Yong-Eun Koo Lee,et al.  Assessing the barriers to image-guided drug delivery. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[30]  S. Esener,et al.  Fluorescent microscope system to monitor real-time interactions between focused ultrasound, echogenic drug delivery vehicles, and live cell membranes. , 2013, Ultrasonics.

[31]  Tom Leslie,et al.  Spatiotemporal monitoring of high-intensity focused ultrasound therapy with passive acoustic mapping. , 2012, Radiology.

[32]  Douglas L. Miller,et al.  In Vivo Gas Body Efficacy for Glomerular Capillary Hemorrhage Induced by Diagnostic Ultrasound in Rats , 2010, IEEE Transactions on Biomedical Engineering.

[33]  A. Marian.  Contemporary treatment of hypertrophic cardiomyopathy. , 2009, Texas Heart Institute journal.